Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: April 8, 2005
Subject: Regulation FD Disclosure regarding a subpoena from the New York Attorney General.
Key Financial Metrics
This filing does not contain financial performance data. No revenue, profit, cash flow, margin, debt, or liquidity figures are reported in this document.
Material Changes
The filing discloses a material legal development rather than a financial change. McKesson Corporation received a subpoena from the Office of the Attorney General of the State of New York. The subpoena seeks the production of documents and information relating to the secondary wholesale market for pharmaceutical products.
Outlook, Risks, and Management Commentary
- Management Response: The Company stated it intends to respond fully to the subpoena.
- Risk/Contingency: The investigation into the secondary wholesale pharmaceutical market represents a legal contingency that could result in further regulatory scrutiny or litigation.
- Guidance: No financial guidance or operational outlook is provided in this filing.
Investor Verification Checklist
- Verify the scope of the New York Attorney General's investigation into the secondary wholesale pharmaceutical market.
- Monitor future filings for updates on the Company's response to the subpoena and any potential legal settlements or penalties.
- Review subsequent quarterly reports (10-Q) or annual reports (10-K) for any financial impact or provisions related to this legal matter.